KAPOSI SARCOMA
Clinical trials for KAPOSI SARCOMA explained in plain language.
Never miss a new study
Get alerted when new KAPOSI SARCOMA trials appear
Sign up with your email to follow new studies for KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug combo tested for rare skin cancer – but study never started
Disease control TerminatedThis study aimed to test a combination of two drugs, pembrolizumab and lenvatinib, in people with classic Kaposi sarcoma that had not responded to prior chemotherapy. The goal was to see if the combination could shrink tumors better than standard chemotherapy. However, the study …
Matched conditions: KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
Hidden risk: HIV patients with rare cancers face faster bone loss
Knowledge-focused OngoingThis study reviews past medical records and CT scans from 40 adults with HIV and Kaposi sarcoma or other KSHV-related cancers. Researchers want to find out what factors are linked to bone mineral density loss in these patients. No new treatments or visits are involved; the goal i…
Matched conditions: KAPOSI SARCOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC